Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 95, Issue 2, Pages 178-187
Publisher
Wiley
Online
2019-12-10
DOI
10.1002/ajh.25680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
- (2019) James F. Howard et al. NEUROLOGY
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
- (2018) James Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
- (2018) Peter Ulrichts et al. JOURNAL OF CLINICAL INVESTIGATION
- Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
- (2018) Hanny Al-Samkari et al. ANNALS OF HEMATOLOGY
- M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
- (2018) Leona E. Ling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
- (2017) Peter Kiessling et al. Science Translational Medicine
- Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
- (2017) Anne Zufferey et al. Journal of Clinical Medicine
- Clinical relevance of antiplatelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia
- (2016) S. Cantoni et al. BLOOD
- Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis
- (2016) Indraraj Umesh Doobaree et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk
- (2016) Rutger A. Middelburg et al. Hematology
- Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies
- (2016) Nora P. Goette et al. PLoS One
- Fatigue in immune thrombocytopenia
- (2015) Quentin A. Hill et al. BRITISH JOURNAL OF HAEMATOLOGY
- Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
- (2015) June Li et al. Nature Communications
- Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics
- (2015) Kine Marita Knudsen Sand et al. Frontiers in Immunology
- Laboratory testing for platelet antibodies
- (2013) Nahla M. Heikal et al. AMERICAN JOURNAL OF HEMATOLOGY
- Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
- (2013) F. Rodeghiero et al. BLOOD
- Immune Thrombocytopenia
- (2013) Gaurav Kistangari et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis
- (2013) Dilip K. Challa et al. mAbs
- Immune Thrombocytopenia: Pathophysiologic and Clinical Update
- (2012) Roberto Stasi SEMINARS IN THROMBOSIS AND HEMOSTASIS
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
- (2011) C. Neunert et al. BLOOD
- Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)
- (2011) Abderrahim Najaoui et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP)
- (2010) Ameet Sarpatwari et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
- (2010) A. Sarpatwari et al. HAEMATOLOGICA
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
- (2010) Gregory Cheng et al. LANCET
- Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
- (2009) Diane Nugent et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antiplatelet Antibodies in Chronic Immune Thrombocytopenia and Their Role in Platelet Destruction and Defective Platelet Production
- (2009) Robert McMillan HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey
- (2008) Claire F. Snyder et al. CURRENT MEDICAL RESEARCH AND OPINION
- Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective
- (2008) Susan D Mathias et al. Health and Quality of Life Outcomes
- Serum Immunoglobulins and Risk of Infection: How Low Can You Go?
- (2008) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura
- (2007) Robert McMillan et al. AMERICAN JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started